(UroToday.com) Dr. Angelika Borkowetz concluded the midterm oncological results for focal therapy thematic session discussing the utility of VTP Tookad. VTP Tookad utilizes padeliporfin vascular-targeted photodynamic therapy to treat clinically localized prostate cancer. Inclusion criteria for VTP are as follows: